Unveiled Truth: Canadian Government Agreement With Pfizer Acknowledges Unknown Long-term Effectiveness and Safety of COVID-19 Vaccines
The Canadian Independent, an independent news source, has shed light on the contract signed between the Canadian government and Pfizer for the supply of COVID-19 vaccines. The contract, signed on October 26, 2020, was signed under emergency and accelerated conditions, with limited long-term data available at the time.
Despite the promotions by politicians, public health officials, the CEO of Pfizer, and the mainstream media, the contract explicitly states that the long-term effects and efficacy of the vaccine were not known at the time of signing. Section 5.5 of the contract clearly outlines this, stating that the long-term safety and efficacy profiles were still emerging.
The mass vaccination of Canadian citizens began approximately two months after the contract was signed. It's important to note that the contract does not guarantee the long-term efficiency or safety of the Pfizer COVID-19 vaccine.
This revelation aligns with the global circumstances during the early vaccine rollout, where regulatory approvals and contracts were based on available clinical trial data and interim evidence under accelerated regulatory processes, rather than complete long-term data.
Fast forward to August 2025, Pfizer Canada announced that Health Canada had authorized an updated COVID-19 vaccine targeting the latest Omicron LP.8.1 variant for use in individuals six months and older. This authorization was based on a cumulative body of evidence, including clinical, non-clinical, and real-world data submitted by Pfizer and BioNTech, reflecting data gathered since the vaccine’s initial rollout.
In summary, the original Pfizer vaccine contracts were signed under emergency and accelerated conditions with limited long-term data. Ongoing regulatory approvals like the one in 2025 for new variant-adapted vaccines are supported by more extensive evidence accumulated over time, including real-world effectiveness and safety data.
The contract obtained by The Canadian Independent would likely reflect that long-term safety and efficacy profiles were still emerging at the time of the contract. The population was not aware of the acknowledgement in the contract of potential unknown effects and long-term efficacy of the Pfizer COVID-19 vaccine.
The news article about the contract was written by Rhoda Wilson and published on Expose-News.com. The Canadian Independent obtained the contract exclusively through an access to information request. This article serves as a reminder of the importance of transparency and thorough understanding of contracts during times of crisis.
- The contract obtained by The Canadian Independent through an access to information request, published on Expose-News.com, underscores the fact that long-term safety and efficacy profiles of the Pfizer COVID-19 vaccine were still emerging at the time of the contract.
- It's worth noting that the original Pfizer vaccine contract was signed under emergency and accelerated conditions, with limited long-term data, indicating that the population was unaware of the acknowledgement in the contract of potential unknown effects and long-term efficacy of the Pfizer COVID-19 vaccine, as detailed in articles like the one published by Rhoda Wilson on Expose-News.com.
